TY - CHAP M1 - Book, Section TI - Protein Kinase Inhibitors and Pathway-Targeted Small Molecules A1 - Wellstein, Anton A1 - Giaccone, Giuseppe A2 - Brunton, Laurence L. A2 - Knollmann, Björn C. PY - 2023 T2 - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition AB - AbbreviationsABC: ATP-binding cassetteABL: Abelson murine leukemia viral oncogene homologALK: anaplastic lymphoma kinaseALL: acute lymphoblastic leukemiaAML: acute myelocytic leukemiaAPML: acute promyelocytic leukemiaARNT: aryl hydrocarbon receptor nuclear translocator (also known as HIF-1β)ATO: arsenic trioxideAUC: area under the curveBCC: basal cell carcinomaBCL: B-cell lymphomaBCR: breakpoint cluster region (chr22)BCRP: breast cancer resistance proteinBH: BCL2 homology domainBIM: BCL2-like protein 11BRCA: breast cancer susceptibility geneBRK: breast tumor kinase, PTK6BTK: Bruton tyrosine kinaseCDK: cyclin-dependent kinaseCLL: chronic lymphocytic leukemiaCML: chronic myelocytic leukemiaCRL4-CRBN: cullin-RING ubiquitin ligase cereblon complexcuSCC: cutaneous squamous cell carcinomaCXCR4: C-X-C chemokine receptor 4DNMT: DNA methyltransferaseECG: electrocardiogramEGF(R): epidermal growth factor (receptor) = HER1EML4: echinoderm microtubule-associated protein-like 4ER: estrogen receptorERK: extracellular signal-related kinase = MAPKFGF(R): fibroblast growth factor (receptor)FIP1L1: factor interacting with poly (A) polymeraseFKBP12: immunophilin-binding protein for tacrolimus (FK506)FL: follicular B-cell non-Hodgkin lymphomaFLT(1 or 4): fms-related tyrosine kinase (1 or 4) (= VEGFR1 or 3)FMO3: flavin containing monooxygenase 3GI: gastrointestinalGIST: gastrointestinal stromal tumorHDAC: histone deacetylaseHER1/2: human epidermal growth factor receptor; 1 = EGFR; 2 = erbB22-HG: 2-hydroxyglutarateHGF(R): hepatocyte growth factor (receptor) = cMETHIF-1 or -2: hypoxia-inducible factor 1 or 2HMT: histone methyltransferaseHSC: hematopoietic stem cellIFN: interferonIGF1R: insulin-like growth factor 1 receptorIκB: inhibitor of nuclear factor kappa BIL: interleukinIMiDs: immunomodulatory imide drugs (e.g., thalidomide)ITK: inducible T-cell kinaseKDR: kinase insert domain receptor = VEGFR2KIT: feline sarcoma virus oncogene homologLCK: lymphocyte-specific kinaseMAPK: mitogen-activated extracellular signal regulated protein kinase = ERKMCL: mantle cell lymphomaMCyR: major cytogenetic responseMDS: myelodysplastic syndromeMEK: mitogen-activated extracellular signal regulated protein kinase kinase = MKKMET: mesenchymal-epithelial transition factor (= HGFR)MM: multiple myelomamTOR: mammalian or mechanistic target of rapamycinNCCN: National Comprehensive Cancer NetworkNET: neuroendocrine tumorNF-κB: nuclear factor-κBNK: natural killerNPM: nucleophosmin (gene)NRAS: neuroblastoma RAS virus homologNSCLC: non–small cell lung cancerOATP: organic anion-transporting polypeptidePARP: poly(ADP-ribose) polymerasePDGF(R): platelet-derived growth factor (receptor)Pgp: P-glycoproteinPI3K: phosphatidylinositol 3-kinasePIK3CA: PI3K catalytic subunit α gene; codes for the p110α enzymePIP2: phosphatidylinositol 4,5-bisphosphatePIP3: phosphatidylinositol (3,4,5)-trisphosphatePNET: peripheral neuroendocrine tumorPPES: palmar-plantar erythrodysesthesia syndromePPI: proton pump inhibitorPROTAC: proteolysis-targeting chimeraPTEN: phosphatase and tensin homologRb: retinoblastoma (protein)RCC: renal cell carcinomaRET: “rearranged during transfection” receptor tyrosine kinaseROS1: orphan receptor tyrosine kinaseSDF: stromal cell-derived factorSLL: small lymphocytic lymphomaTGF: transforming growth factorTIE: tyrosine kinase with Ig and EGF domainsTKI: tyrosine kinase inhibitorTSC: tuberous sclerosis complexVEGF(R): vascular endothelial growth factor (receptor)VHL: von Hippel-Lindau (pVHL = VHL protein) SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/04/18 UR - hemonc.mhmedical.com/content.aspx?aid=1193242501 ER -